
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Pioneering genetic research to advance diagnosis and therapies for inherited retinal diseases.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
Total Funding | 000k |
IOB is an international research institute focused on advancing the understanding and treatment of inherited retinal diseases. By conducting extensive genetic studies, particularly in regions like Pakistan, IOB aims to uncover unique mutational patterns that can inform diagnosis and future therapies. The institute operates within the biomedical research sector, leveraging substantial financial support from the Canton of Basel Stadt. IOB fosters a collaborative environment that values diversity and interdisciplinary exchange, uniting researchers and clinicians in the mission to restore vision. The business model is centered around research and development, with funding from public and private partnerships. Key clients include academic institutions, healthcare providers, and governmental bodies interested in genetic research and therapeutic advancements.
Keywords: genetic research, retinal diseases, diagnosis, therapies, interdisciplinary, collaboration, biomedical, public-private, vision restoration, Basel.